ZA97215B - Use of the i-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer - Google Patents

Use of the i-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer

Info

Publication number
ZA97215B
ZA97215B ZA97215A ZA97215A ZA97215B ZA 97215 B ZA97215 B ZA 97215B ZA 97215 A ZA97215 A ZA 97215A ZA 97215 A ZA97215 A ZA 97215A ZA 97215 B ZA97215 B ZA 97215B
Authority
ZA
South Africa
Prior art keywords
centchroman
enantiomer
prophylaxis
manufacture
treatment
Prior art date
Application number
ZA97215A
Inventor
Michael Shalmi
Ved Prakash Kamboj
Omkar Prasad Asthana
Suprabhat Ray
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA97215B publication Critical patent/ZA97215B/en

Links

ZA97215A 1996-01-11 1997-01-10 Use of the i-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer ZA97215B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1000096P 1996-01-11 1996-01-11

Publications (1)

Publication Number Publication Date
ZA97215B true ZA97215B (en) 1997-07-21

Family

ID=21743237

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA97215A ZA97215B (en) 1996-01-11 1997-01-10 Use of the i-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer

Country Status (1)

Country Link
ZA (1) ZA97215B (en)

Similar Documents

Publication Publication Date Title
EP0942742A4 (en) Therapeutic compositions for treatment of cancer
IL112969A0 (en) Pharmaceutical composition comprising t-cell actiVator for the treatment of cancer
AU1980995A (en) Methods and compositions for treatment of breast cancer
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
IL132287A0 (en) Compositions and methods for the treatment and diagnosis of breast cancer
IL124881A0 (en) Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer
AU5005197A (en) Prophylaxis of breast cancer
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
HUP9802634A3 (en) Use of benzimidazoles for the manufacture of pharmaceutical compositions for the treatment of leukemia
IL101245A0 (en) Pharmaceutical compositions for the treatment of prostatic cancer
IL101410A0 (en) Formulation for the treatment of cancer
EP0577023A3 (en) Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
IL121329A0 (en) A pharmaceutical composition for the treatment of cancer
IL116733A0 (en) The use of sertraline to treat cancer patients
AU5627796A (en) Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury
GB9510162D0 (en) Compositions for the treatment of skin conditions
ZA97215B (en) Use of the i-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer
EP0918788A4 (en) Brca1 compositions and methods for the diagnosis and treatment of breast cancer
IL143671A0 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF BREAST CANCER COMPRISING hCG
EP0755262A4 (en) Composition for the treatment of lung disease
IL106763A0 (en) Pharmaceutical compositions for treating cancer
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
GB9219776D0 (en) New compounds for use in the treatment of cancer
GB2312375B (en) Agents for treatment of cancer
HU9700079D0 (en) Topical compositions for the treatment of skin disease